stockrowAbCellera Biologics Inc.
ABCL Healthcare Biotechnology
AbCellera Biologics Inc.’s revenue for fiscal 2025 (year ended December 2025) was $75.1 million, up 160.6% from fiscal 2024.
- Revenue
- −76.3%
- EPS
- −50.0%
- Free cash flow
- +152.0%
Quarter to June 2026, against a year earlier
Follow ABCL
Alert me
AbCellera Biologics Inc. (ABCL) Operating margin
AbCellera Biologics Inc.'s operating margin over the twelve months to 30 June 2026 was −340.3%, down 51.3 percentage points from fiscal 2025 (−289.0%). Over the past ten years it has ranged from −1,091.7% (fiscal 2024) to 66.9% (fiscal 2020); the current reading is higher than 38% of that period. That is below the Biotechnology industry median of 0.00% and below the Healthcare sector median of 0.00%.
Operating margin, annual
Embed this chart
Annual newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| FY2025 | −289.0% | 802.71 |
| FY2024 | −1,091.7% | (467.87) |
| FY2023 | −623.8% | (668.42) |
| FY2022 | 44.6% | (9.88) |
| FY2021 | 54.5% | (12.44) |
| FY2020 | 66.9% | 102.37 |
| FY2019 | −35.5% | (26.92) |
| FY2018 | −8.53% | — |
Quarterly newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| Jun 2026 | −1,550.1% | (858.30) |
| Mar 2026 | −691.8% | (628.03) |
| Dec 2025 | −63.7% | 788.07 |
| Sep 2025 | −851.8% | (561.55) |
| 22 more quarters | Free account |
Against its own ten years
Operating margin against peers
| Company | Operating margin |
|---|---|
| ACAD ACADIA Pharmaceuticals Inc. compare | 10.2% |
| ARQT Arcutis Biotherapeutics, Inc. compare | 6.91% |
| XENE Xenon Pharmaceuticals Inc. compare | 0.00% |
| EWTX Edgewise Therapeutics, Inc. compare | 0.00% |
| PBLS Parabilis Medicines, Inc. compare | 0.00% |
| TNGX Tango Therapeutics, Inc. compare | 0.00% |
| IOVA Iovance Biotherapeutics, Inc. compare | −60.8% |
| ABCL AbCellera Biologics Inc. | −340.3% |
| RLAY Relay Therapeutics, Inc. compare | −2,815.5% |
| Biotechnology industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Operating margin is
EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.
EBIT ÷ Revenue
More on ABCL
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement